Hong Kong Island, Hong Kong, China Janchor Partners is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Central. The venture was found in Asia in Hong Kong.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are PAG, OrbiMed, Heritage Provider Network. In the next rounds fund is usually obtained by PAG, Hudson Bay Capital Management, China Venture Capital.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Alphamab Oncology. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology.
The top activity for fund was in 2018. The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of more than 100 millions dollars.
This organization was formed by John Ho.
Related Funds
| Fund Name | Location |
| American Airlines | Fort Worth, Texas, United States |
| Baker Brothers Advisors LLC | New York, New York, United States |
| Dunamu & Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| Echo Ventures | Malaysia, Selangor, Selangor |
| Emerging Technology Partners | California, San Francisco, United States |
| Forbes Family Trust | New York, New York, United States |
| Global Millennial Capital | Dubai, United Arab Emirates |
| Hanseatic Americas | New York, New York, United States |
| Ignite Venture Partners | Arizona, Scottsdale, United States |
| McDonald Partners | Cleveland, Ohio, United States |
| Miller Center for Social Entrepreneurship | California, Santa Clara, United States |
| Narya Capital | Illinois, Ohio, United States |
| Rungkai Capital | Beijing, Changyang, China |
| ShenZhen QianHai Red Lotus Fund Management Co., Ltd. | China, Guangdong, Shenzhen |
| Strategic Equities | - |
| Think.Health | Bavaria, Bayern, Germany |
| V8 Capital Partners | Ebène, Mauritius, Plaines Wilhems |
| Venvest Capital | California, Santa Monica, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
FPL Technologies | $75M | 30 Dec 2021 | Pune, Maharashtra, India | ||
MediTrust Health | $308M | 10 Aug 2021 | Xuhui, Shanghai, China | ||
Everest Medicines | $310M | 03 Jun 2020 | New York, New York, United States | ||
Rongchang Pharmaceutical | 16 Mar 2020 | Huludao City, Liaoning, China | |||
Alphamab Oncology | $100M | 16 Nov 2018 | China, Jiangsu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
FPL Technologies | $75M | 30 Dec 2021 | Pune, Maharashtra, India | ||
MediTrust Health | $308M | 10 Aug 2021 | Xuhui, Shanghai, China | ||
Everest Medicines | $310M | 03 Jun 2020 | New York, New York, United States | ||
Rongchang Pharmaceutical | 16 Mar 2020 | Huludao City, Liaoning, China | |||
Alphamab Oncology | $100M | 16 Nov 2018 | China, Jiangsu |
